Welcome : Guest

Lexicon Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Lexicon Pharmaceuticals, Inc., which is principally a Biopharmaceutical Company. Illustrated with 127 tables, the report showcases the company's recent news stories and events, key markets and market position as against its competitors operating in the industry.

Code: PCP-10448
Price: $3500
Company Type: Public
Pages: 130
Date: February 2017
Market Data Tables: 127

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Biopharmaceuticals......2
Table 1: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......2
Diabetes......3
Table 2: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......3
Table 3: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-Like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others......4
Table 4: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......5
Table 5: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......6
Table 6: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......7
Table 7: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......8
Table 8: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......9
Table 9: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......10
Table 10: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......11
Table 11: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......12
Diabetes Drugs......13
Table 12: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......13
Table 13: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......14
Table 14: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......15
Table 15: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......16
Table 16: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......17
Table 17: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......18
Table 18: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......19
Table 19: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......20
Table 20: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......21
Table 21: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......22
Table 22: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......23
Non-Insulin Anti-Diabetic Drugs......24
Table 23: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......24
Diabetic Macular Edema (DME)......25
Table 24: Diabetic Macular Edema (DME) Market by Drug Treatment Worldwide (2015) - Percentage Share Breakdown by Volume for Avastin, Laser Photocoagulation, Lucentis 0.3 mg, Steroids and Others......25
Table 25: Diabetic Macular Edema (DME) Anti Vascular Endothelial Growth Factor (VEGF) Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Avastin, Lucentis and Others......26
Insulin......27
Table 26: Insulin Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Aspart (Novolog), Detemir (Levemir), Glargine (Lantus), Glulisine (Apidra), Lispro (Humalog), and Rh Insulin......27
Table 27: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Basal Insulins, Prandial Insulins and Pre-Mixed Insulin......28
Table 28: Insulin Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Fast Acting, Long Acting and Premix......29
Table 29: Insulin Market by Generation in China (2015) - Percentage Share Breakdown by Value for 1st Generation, 2nd Generation, and 3rd Generation......30
Table 30: Insulin Market by Product Type in the US (2015) - Percentage Share Breakdown by Value for Fast-Acting, Human, Long-Acting and Mix......31
DPP-4 Inhibitors......32
Table 31: DPP-4 Inhibitors Market by Product Category Worldwide (2015) - Percentage Share Breakdown by Value for Galvus & Galvumet (Novartis), Januvia & Janumet (MRK), Nesina & Kezano (Takeda), Onglyza & Kombiglyze (AZN/BMY) and Tradjenta & Jentadueto (BI/Lilly)......32
Table 32: DPP-4 Inhibitors Market in China (2015-2020) in RMB Million......33
Table 33: DPP-4 Inhibitors (Fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Galvusmet, Janumet, Janumet XR, Kombiglyze, Trajenta Duo and Zemimet......34
Table 34: DPP-4 Inhibitors (Non-fixed Dose) Market by Product Category in Korea (2015) - Percentage Share Breakdown by Value for Januvia, Nesina, Tradjenta, Zemiglo, and Others......35
Table 35: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......36
Table 36: DPP-4 Inhibitors Market in the US (2015) in No. of Prescriptions......37
DPP-4 type Diabetes Drugs......38
Table 37: DPP-4 type Diabetes Drugs Market in Japan (2015) in Yen Million......38
Cancer Drugs......39
Table 38: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......39
Table 39: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......40
Cancer Market......41
Table 40: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......41
Table 41: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......42
Table 42: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......43
Table 43: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......44
Table 44: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......45
Table 45: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......46
Table 46: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......47
Table 47: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......48
Cancer Patients......49
Table 48: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......49
Table 49: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......50
Table 50: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......51
Table 51: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......52
Table 52: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......53
Table 53: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......54
Table 54: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......55
Table 55: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......56
Table 56: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......57
Table 57: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......58
Table 58: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......59
Table 59: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......60
Table 60: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......61
Table 61: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......62
Table 62: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......63
Table 63: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......64
Table 64: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......65
Table 65: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......66
Table 66: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......67
Table 67: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......68
Table 68: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......69
Cervical Cancer......70
Table 69: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......70
Table 70: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......71
Hematological Cancer......72
Table 71: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......72
Skin Cancer......73
Table 72: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......73
Cancer-Associated Mucositis......74
Table 73: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......74
Chronic Myelogenous Leukemia (CML)......75
Table 74: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......75
Multiple Myeloma......76
Table 75: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......76
Table 76: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......77
Immunology......78
Table 77: Immunology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dermatology, Gastroenterology, and Rheumatology......78
Gastrointestinal Drugs......79
Table 78: Gastrointestinal Market Worldwide (2015) in US$ Million......79
Table 79: Gastrointestinal Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for H2 Blockers, Proton Pump Inhibitors, and Others......80
Cardiology......81
Table 80: Cardiology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cardiac Rhythm Management & Congestive Heart Failure Devices, Cardiac Surgery, and Interventional Cardiology......81
Table 81: Cardiovascular Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Angiotensin Receptor Blockers, Anti-Arrhythmics, Anti-Thrombotics, Beta Blockers, Calcium Channel Blockers, Cholesterol, GP IIb/IIIa Inhibitors, Vasodilators, and Others......82
Table 82: Cardiology Market by Category in the US (2015) - Percentage Breakdown by Value Sales for ACE Inhibitors, Alpha Blockers, Anti-Arrhythmics, ARB's, Beta Blockers, Calcium Blockers, Cholesterol, Digitalis, Diuretics, Vasodilators, and Others......83
Rheumatoid Arthritis......84
Table 83: Rheumatoid Arthritis Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for ENBREL, HUMIRA, REMICADE, and Others......84
Biopharmaceuticals......85
Table 84: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......85
Table 85: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......86
Diabetes Drugs......87
Table 86: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......87
Table 87: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......88
Table 88: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......89
Insulin......90
Table 89: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......90
Table 90: Market Shares of Leading Insulin Companies Worldwide (2014) - Percentage Breakdown by Volume Sales for Eli Lilly and Company, Novo Nordisk A/S, Sanofi S.A., and Others......91
Table 91: Market Shares of Leading Fast & Intermediate Type Insulin Producers Worldwide (2015) - Percentage Share Breakdown by Value for Eli Lilly and Company, Novo Nordisk, Sanofi S.A. and Others......92
Table 92: Market Shares of Leading Long-Acting Insulin Producing Companies Worldwide (2015) - Percentage Share Breakdown by Value for Sanofi S.A., Wockhardt Ltd., and Others......93
Table 93: Market Shares of Leading Insulin Companies in China (2014) - Percentage Share Breakdown by Value for Eli Lilly and Company, GanLee Pharmaceutical Co., Ltd., Novo Nordisk, Sanofi S.A., Shanghai Fosun Pharmaceutical Group Co., Ltd., United Laboratories International Holdings Ltd. (The), Tonghua Dongbao Pharmaceutical Co., Ltd., and Others......94
Table 94: Market Shares of Leading Insulin Companies in China (2015) - Percentage Share Breakdown by Volume for Novo Nordisk, Tonghua Dongbao Pharmaceutical Co., Ltd., Wanbang Biopharmaceuticals Co., Ltd. and Others......95
Table 95: Market Shares of Leading Insulin Companies in Europe (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......96
Table 96: Market Shares of Leading Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Ltd., Cadila Pharmaceuticals Ltd., Eli Lilly and Company India Pvt. Ltd., Lupin Pharmaceuticals, Inc., Novo Nordisk India Ltd., Pfizer India Ltd., Ranbaxy Laboratories Ltd., Sanofi India Ltd., Shreya Life Sciences Pvt. Ltd., USV Ltd., and Wockhardt Ltd.......97
Table 97: Market Shares of Leading Insulin Companies in Japan and Korea (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......98
Table 98: Market Shares of Leading Insulin Companies in North America (2014) - Percentage Breakdown by Volume Sales for Novo Nordisk A/S, and Others......99
Second-Generation Insulin......100
Table 99: Market Shares of Leading Second-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Novo Nordisk, The United Laboratories International Holdings, Ltd., and Tonghua Dongbao Pharmaceutical Co., Ltd.......100
Third-Generation Insulin......101
Table 100: Market Shares of Leading Third-Generation Insulin Companies in China (2014) - Percentage Share Breakdown by Volume for Eli Lilly and Company, Gan & Lee Pharmaceutical, Ltd., Novo Nordisk, and Sanofi S.A.......101
Human Insulin......102
Table 101: Market Shares of Leading Human Insulin Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Biocon Limited, Eli Lilly and Company India Pvt. Ltd., Novo Nordisk India Limited, Sanofi India Limited, Wockhardt Ltd., and Others......102
DPP-4 Inhibitors......103
Table 102: Market Shares of Leading DPP-4 Inhibitors Manufacturers by Value Sales Worldwide (2015) - Percentage Share Breakdown for Merck & Co., Inc. (Januvia/Janumet), Novartis AG (Galvus/Galvumet) and Takeda Pharmaceutical Co., Ltd. (Nesina/Kezano), and Others......103
Table 103: Market Shares of Leading DPP-4 Inhibitors for Treatment of Diabetes in Japan (2015) - Percentage Share Breakdown by Value for Equa, Glactiv, Januvia, Nesina, and Others......104
Table 104: Market Shares of Leading DPP-4 Drug Brands in China (2015) - Percentage Share Breakdown by Value for Galvus, Januvia, Onglyza, and Others......105
Sitagliptin/Metformin......106
Table 105: Market Shares of Leading Sitagliptin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Istavel and Januvia......106
Table 106: Market Shares of Leading Sitagliptin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd.......107
Table 107: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......108
Table 108: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......109
Metformin......110
Table 109: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......110
Ophthalmology Drugs......111
Table 110: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......111
Table 111: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......112
Cancer Drugs......114
Table 112: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......114
Table 113: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......115
Table 114: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......116
Table 115: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......117
Table 116: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......118
Breast Cancer Drugs......119
Table 117: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......119
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......120
Table 118: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......120
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......121
Table 119: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Other......121
Table 120: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......122
Gastrointestinal Drugs......123
Table 121: Market Shares of Leading Gastrointestinal, Ulcer Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Pfizer, Inc., and Others......123
Table 122: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......124
Table 123: Market Shares of Leading Gastrointestinal (GI) Remedies Manufacturers for Over- the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for GlaxoSmithKline Pharmaceuticals Limited, Johnson & Johnson Private Limited, Novartis Consumer Health, Inc., Prestige Brands Holdings, Inc., Procter & Gamble Co., Private Label and Others......125
Table 124: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Value Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......126
Table 125: Market Shares of Leading Gastrointestinal Medicine Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Procter & Gamble Co., and Others......127
Cardiology Therapeutic......128
Table 126: Market Shares of Leading Cardiology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......128
Table 127: Lexicon Pharmaceuticals, Inc.’s Revenues by Category Worldwide (2011-2013) in US$ Thousands for Collaborative Research and Subscription and License Fees......129